BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

391 hedge funds and large institutions have $12.4B invested in BioMarin Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 163 increasing their positions, 120 reducing their positions, and 38 closing their positions.

Holders
391
Holders Change
+1
Holders Change %
+0.26%
% of All Funds
10.45%
Holding in Top 10
13
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.35%
New
45
Increased
163
Reduced
120
Closed
38
Calls
$102M
Puts
$87.3M
Net Calls
+$14.6M
Net Calls Change
-$20.3M

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$87.2M
2
PAMU
2
Pictet Asset Management (UK)
United Kingdom
$86.8M
3
HM
3
HealthCor Management
New York
$58.4M
4
IG
4
ING Group
Netherlands
$57.4M
5
PHS
5
PFM Health Sciences
California
$44.4M

Top Sellers

1
Royal London Asset Management
1
Royal London Asset Management
United Kingdom
$4.32M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$274M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$862M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$263M
5
SAM
5
Sectoral Asset Management
Quebec, Canada
$38.5M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.23B 15,853,303 +8 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$891M 11,448,690 +346,369 +3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$862M 11,073,345 -2,386,118 -18%
Sands Capital Management
4
Sands Capital Management
Virginia
$849M 10,918,317 -643,187 -6%
Jennison Associates
5
Jennison Associates
New York
$704M 9,051,244 +301,353 +3%
Primecap Management
6
Primecap Management
California
$569M 7,319,319 -31,050 -0.4%
BBA
7
Baker Bros. Advisors
New York
$374M 4,806,483 – –
BIT
8
BlackRock Institutional Trust
California
$305M 3,917,865 +108,349 +3%
BFA
9
BlackRock Fund Advisors
California
$291M 3,737,456 +54,123 +1%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$274M 3,525,314 -2,693,446 -43%
Temasek Holdings
11
Temasek Holdings
Singapore
$270M 3,472,712 – –
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$263M 3,375,543 -1,110,895 -25%
State Street
13
State Street
Massachusetts
$261M 3,349,037 +62,294 +2%
Wells Fargo
14
Wells Fargo
California
$195M 2,504,627 -152,185 -6%
Invesco
15
Invesco
Georgia
$183M 2,357,862 -106,783 -4%
O
16
OppenheimerFunds
New York
$161M 2,069,013 +201,629 +11%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$141M 1,810,788 +346,359 +24%
PAI
18
Palo Alto Investors
California
$135M 1,737,399 +397,052 +30%
Citadel Advisors
19
Citadel Advisors
Florida
$129M 1,653,983 -540,892 -25%
O
20
OrbiMed
New York
$118M 1,518,500 +495,300 +48%
Ameriprise
21
Ameriprise
Minnesota
$115M 1,479,745 +168,586 +13%
FAM
22
Fred Alger Management
New York
$112M 1,435,787 +196,503 +16%
TCIM
23
TIAA CREF Investment Management
New York
$109M 1,395,816 -149,568 -10%
Deutsche Bank
24
Deutsche Bank
Germany
$107M 1,378,924 +43,660 +3%
Franklin Resources
25
Franklin Resources
California
$106M 1,361,996 +1,106 +0.1%
1
2 3 4 5